Molecules · 2023 · 11 citations · 28 references
Life SciencesNeurosciencePharmacologyAutophagyCellular NeuroscienceMolecular NeuroscienceAutophagy DysfunctionAutophagy Signaling PathwaysLysosomal DysfunctionNeuronal Cell DeathNeuroprotectionNeuroprotective PharmacologyAutophagy PathwayAutophagy-lysosome DysfunctionCell Viability AssaysCell Viability PreservationNeuronal Injury ResponseNeuroprotective AgentsNeuroprotective ResponsesNeuroprotective Signaling
and investigated for its neuroprotective effect towards oxygen-glucose deprivation/re-oxygenation (OGD/R)-induced neuronal damage. In this study, primary cortical neurons were pre-treated with THA and then subjected to OGD/R induction. The cell viability was tested by the MTT assay, and the states of the autophagy-lysosomal pathway and Akt/mTOR pathway were monitored by Western blot analysis. The findings suggested that THA administration increased the cell viability of OGD/R-induced cortical neurons. Autophagic activity and lysosomal dysfunction were found at the early stage of OGD/R, which were significantly ameliorated by THA treatment. Meanwhile, the protective effect of THA was significantly reversed by the lysosome inhibitor. Additionally, THA significantly activated the Akt/mTOR pathway, which was suppressed after OGD/R induction. In summary, THA exhibited promising protective effects against OGD/R-induced neuronal injury by autophagy regulation through the Akt/mTOR pathway.
28
Valery L. Feigin, Benjamin Stark, Catherine O. Johnson et al. · The Lancet Neurology · 2021 · 7.6K citations · Full text
Tsc1 (hamartin) confers neuroprotection against ischemia by inducing autophagy
Michalis Papadakis, Gina Hadley, Maria Xilouri et al. · Nature Medicine · 2013 · 235 citations
Yang Qu, Michael L. A. E. Easson, Razvan Simionescu et al. · Proceedings of the National Academy of Sciences · 2018 · 162 citations · Full text